Fractyl Health, Inc. (GUTS) stock forecast and price target
Price $0.90 · data as of November 13, 2026
12-month price target
Average target$23.80
Upside / downside+2533.9%
Analysts5
ConsensusStrong buy
Low $4.00Average $23.80High $46.00
Gold marker: average target · white marker: today’s price ($0.90)
Analyst ratings
Strong buy 0Buy 6Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-3.39 | +84.8% | $0 |
| Next fiscal year ends December 31, 2027 | $-2.90 | +14.4% | $100000 |
| Next quarter ends December 31, 2026 | $-1.08 | −28.6% | $0 |
| Quarter after ends March 31, 2027 | $-0.23 | +85.0% | $0 |
Consensus of the analysts covering Fractyl Health, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.
Frequently asked questions
What is the Fractyl Health stock price target?
The average 12-month target from 5 analysts is $23.80, 2533.9% above the current price of $0.90 Targets range from $4.00 to $46.00.
Is Fractyl Health a buy according to analysts?
The consensus rating is “Strong buy” (6 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Fractyl Health expected to earn?
Analysts expect EPS of $-3.39 for the fiscal year ending December 31, 2026 and $-2.90 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.